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In contrast to the 70 to 80 viral genes expressed during
productive infection, LR RNA is the only abundant viral transcript detected in latently infected neurons. A small fraction of
LR RNA is polyadenylated and alternatively spliced in trigeminal ganglia, suggesting this RNA is translated into an LR
protein (5, 13). LR gene products inhibit S-phase entry, and
LR protein is associated with cyclin-dependent kinase 2
(Cdk2)-cyclin complexes (13, 15). LR gene products also promote cell survival following induction of apoptosis in transiently transfected cells (4). Although these studies imply that
the LR gene plays a role in latency and/or pathogenesis, the
effects of LR gene products on growth of the virus in cultured
cells or in cattle has not been studied.
In this study, we constructed an LR mutant virus that contains three stop codons near the beginning of the LR RNA.
The LR mutant had growth properties similar to those of the
WT in productively infected bovine kidney (MDBK) cells.
Since HSV-1 latency-associated transcript (LAT) null mutants
have growth properties in tissue culture cells and infected
rabbits or mice similar to those of wild-type (WT) virus (reviewed in references 16 and 33), this result was expected.
Surprisingly, calves infected with the LR mutant consistently
exhibited diminished clinical symptoms and ocular shedding. However, similar levels of the LR mutant, WT BHV-1,
and the LR rescued virus were shed from the nasal cavities
of calves during acute infection. Taken together, these results suggested that LR gene products promote virus growth
in certain cell types in the eye or optic nerve during acute
infection of cattle.

Bovine herpesvirus 1 (BHV-1) is an important viral pathogen of cattle that can cause severe respiratory infection, conjunctivitis, abortions, vulvovaginitis, balanopostitis, and generalized systemic infection in neonate calves (40). BHV-1induced immunosuppression frequently leads to secondary
bacterial infections, resulting in bronchopneumonia and occasionally death. Increased susceptibility to secondary infection
correlates with depressed cell-mediated immunity after infection (2, 8–10). CD8⫹-T-cell recognition of infected cells is
impaired by down regulation of major histocompatibility complex class I expression and the transporter associated with
antigen presentation (11, 12, 22). CD4⫹-T-cell function is impaired during acute infection of calves because BHV-1 has the
ability to infect CD4⫹ T cells and induce apoptosis (34).
BHV-1 belongs to the subfamily Alphaherpesvirinae and
shares a number of biological properties with herpes simplex
virus type 1 (HSV-1) and HSV-2 (16). BHV-1 establishes lifelong latency in ganglionic neurons of the peripheral nervous
system after initial replication in the mucosal epithelium. Virus
reactivation and spread to other susceptible animals occur
after natural or corticosteroid-induced stress (26, 32). Although the primary site of BHV-1 latency is sensory neurons,
there is evidence that long-term persistence and reactivation
also occur within germinal centers of the pharyngeal tonsil
(36).
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Bovine herpesvirus 1 (BHV-1) is an important pathogen of cattle, and infection is usually initiated in the
ocular or nasal cavity. Like other alphaherpesviruses, BHV-1 establishes latency in sensory neurons but has
the potential of reactivating from latency and spreading. The only abundant viral transcript expressed during
latency is the latency-related (LR) RNA, which is alternatively spliced in trigeminal ganglia during acute
infection (L. R. Devireddy and C. Jones, J. Virol. 72:7294–7301, 1998). LR gene products inhibit cell cycle
progression (Y. Jiang, A. Hossain, M. T. Winkler, T. Holt, A. Doster, and C. Jones, J. Virol. 72:8133–8142, 1998)
and chemically induced apoptosis (J. Ciacci-Zannela, M. Stone, G. Henderson, and C. Jones. J. Virol.
73:9734–9740, 1999). Although these studies suggest that LR gene products play an important role in the
latency/pathogenesis of BHV-1, construction of a mutant is necessary to test this hypothesis. Because the bICP0
gene overlaps and is antisense to the LR gene, it was necessary to mutate the LR gene without altering bICP0
expression. This was accomplished by inserting three stop codons near the beginning of the LR RNA, thus
interfering with expression of proteins expressed by the LR RNA. The LR mutant virus grew with wild-type
(WT) efficiency in bovine kidney (MDBK) cells and expressed bICP0 at least as efficiently as WT BHV-1 or the
LR rescued virus. When calves were infected with the LR mutant, we observed a dramatic decrease (3 to 4 log
units) in ocular shedding during acute infection relative to WT or the LR rescued virus. In contrast, shedding
of the LR mutant from the nasal cavity was not significantly different from that of the WT or the LR rescued
virus. Calves infected with the LR mutant exhibited mild clinical symptoms, but they seroconverted. Neutralizing antibody titers were lower in calves infected with the LR mutant, confirming reduced growth. In summary,
this study suggests that an LR protein promotes ocular shedding during acute infection of calves.
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1 min, 60°C for 1 min, and 72°C for 2 min (30 cycles total). To ensure complete
elongation of the amplified products, the reaction mixture was incubated at 72°C
for an additional 10 min. The products were digested with EcoRI and electrophoresed on a 2% agarose gel, and the DNA was visualized by staining it with
ethidium bromide.
Growth characteristics of the LR mutant, detection of virus shedding, and
virus-specific neutralizing antibodies. MDBK cells were infected with various
MOIs of BHV-1 for 1 h at 37°C. The monolayers were then rinsed two times with
phosphate-buffered saline containing 0.5⫻ trypsin to inactivate any surfacebound virus. Complete medium was then added to the cultures to inactivate the
trypsin. At various times, total cell lysate or the supernatant from infected
cultures was subjected to three freeze-thaw cycles, clarified, and titrated on
MDBK cells.
Nasal and ocular swabs were stored at ⫺80°C in 2 ml of tissue culture medium
supplemented with 10 g of amphotericin B (Fungizone)/ml and 45 g of
gentamicin/ml. Samples were thawed quickly in a 37°C water bath, vortexed, and
centrifuged (1,500 ⫻ g for 10 min). All titrations were performed using 10-fold
serial dilution and were plated in quadruplicate.
The Veterinary Diagnostic Service, University of Nebraska, Lincoln, performed neutralizing-antibody titrations utilizing the Cooper strain as the stock
virus.
Western blot analysis of bICP0. After infection of the cells with the different
viruses, whole-cell lysate was collected at various times (13). Proteins (50 g)
were separated by SDS-polyacrylamide gel electrophoresis (10% acrylamide)
and then transferred to Immobilon-P membranes (Millipore, Bedford, Mass.).
The membranes were rinsed for 5 min in TBS (0.02 M Tris base, 0.13 M NaCl,
pH 7.6) and then blocked in a buffer (TBS, 0.1% Tween 20, 5% nonfat dry milk)
for 1 h at room temperature. The membrane was then incubated with rabbit
anti-bICP0 (M. Schwyzer, Zurich, Switzerland) that was diluted 1:1,000 in primary antibody buffer (TBS, 0.1% Tween 20, 5% bovine serum albumin) for 16 h
at 4°C. The membrane was washed three times for 5 min each time with TBS–
0.1% Tween 20. Detection of bound primary antibody was performed using the
ECL detection system (Amersham Pharmacia, Piscataway, N.J.) (using goat
anti-rabbit antibody) as previously described (13). The only change made to this
protocol was to use the blocking buffer mentioned above as the secondary
antibody dilution buffer. For loading controls, the membrane was stripped as
previously described (ECL Western blotting Protocols Manual; Amersham Pharmacia) and reprobed with goat anti-actin antibody (Santa Cruz Biotechnology,
Santa Cruz, Calif.) as the primary antibody. A horse anti-goat peroxidase-conjugated antibody (Santa Cruz Biotechnology) was used for detection as described
above.

RESULTS
Construction of a BHV-1 LR mutant virus. Our previous
studies have focused on performing functional studies of the
LR gene and putative proteins encoded by this gene. These
studies have demonstrated that LR gene products interfere
with cell cycle progression (29) and chemical induction of
apoptosis (4). To test whether BHV-1 LR gene products play
a role in virus growth and/or latency, we constructed a BHV-1
LR mutant virus that contains stop codons near the 5⬘ terminus
of the LR transcript and tested this mutant in cultured cells or
calves.
The LR gene is transcribed antisense with respect to the
immediate-early (IE) and early (E) gene transcript (IE/2.9 and
E/2.6) that encodes bICP0 (Fig. 1A and B). The lytic start site
for the LR RNA is at nt 724 (1, 13), and the first in-frame ATG
for LR open reading frame 2 (ORF2) is at nt 783 to 785 (Fig.
1C), whereas the stop site for bICP0 is at nt 956 (LR numbers)
(7, 37–39), which complicates construction of an LR mutant
virus. The cis-acting sequences that regulate poly(A) addition
for the transcript that encodes bICP0 are also near sequences
that contain the LR gene TATA box. This prevented insertion
of a reporter gene near the start site of LR gene expression or
an extensive deletion of LR gene sequences. Consequently, we
inserted three stop codons that should prevent LR protein
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Virus and cells. The designated cells were plated at a density of 5 ⫻ 105 per
100-mm2 plastic dish in Earle’s modified medium supplemented with 5 to 10%
fetal bovine serum (FBS), penicillin (10 U/ml), and streptomycin (100 g/ml).
Bovine kidney (MDBK) cells (CCL-22; American Type Culture Collection
[ATCC]) were grown in 5% FBS, split 1:6 every 4 to 5 days, and used to
propagate BHV-1. Primary bovine epidermal cells were grown in 10% FBS and
were used to generate the mutant and rescued viruses because they can be
transfected with high efficiency. These cells are immortalized with the simian
virus 40 large T antigen and have fibroblastlike characteristics (11a).
The Cooper strain of BHV-1 (WT virus) was obtained from the National
Veterinary Services Laboratory, Animal and Plant Health Inspection Services,
Ames, Iowa. Viral stocks were prepared by infecting MBDK cells at a multiplicity
of infection (MOI) of 0.001 from a plaque-purified virus and were subsequently
titrated on MDBK cells.
Animal experiments. BHV-1-free crossbred calves (⬇250 kg) were randomly
assigned and housed in isolation rooms to prevent cross contamination. The
calves were anesthetized with Rompun (approximately 50 mg/50 kg of body
weight; Bayer Corp., Shawnee Mission, Kans.). The calves were then inoculated
in each nostril and eye with 1 ml of a solution containing 1 ⫻ 107 PFU of the
indicated virus/ml, without scarification, for a total of 4 ⫻ 107 PFU per animal,
as described previously (30, 34–36). Experiments using animals were performed
in accordance with the American Association of Laboratory Animal Care guidelines. Calves were housed under strict isolation containment and were given
antibiotics before and after BHV-1 infection to prevent secondary bacterial
infection. Nasal swabs, ocular swabs, and serum samples were taken at the
designated times.
Plasmids. The plasmid used for generating the LR mutant (pBlueL/mLAT)
was constructed as follows: 825 bp of the HindIII L fragment that is directly
upstream of the LR promoter (D fragment) was cloned into pBlueBacHisA
(Invitrogen, Carlsbad, Calif.). pBR322-HindIII L fragment contains the HindIII
L fragment of BHV-1 (Cooper strain), and this plasmid was digested with NheI.
The resulting products were treated with mung bean exonuclease (New England
BioLabs) to blunt the ends for ligation of BamHI linkers. After phenol-chloroform extraction, the DNA was digested with HindIII and then BamHI. The
products were electrophoresed on an agarose gel, and the 825-bp product was
isolated. The 825-bp product, containing a 5⬘ BamHI site and a 3⬘ HindIII site,
was ligated into the pBlueBacHis vector digested with BamHI plus HindIII, and
the resulting plasmid was designated pBlueL. A fragment containing the entire
LR promoter and coding region (1,940 bp) was cloned into the HindIII and SalI
sites of pBlueL, and the resulting plasmid was designated pBlueL/LAT. The PstI
fragment (1 to 981 nucleotides [nt]) was excised from pBlueL/LAT and cloned
into the pBlueBacHis vector. This subcloning was performed because there are
three SphI sites in the coding region of the LR gene (781, 812, and 1,777 nt). The
SphI fragment (781 to 812 nt) was excised, and the mutant oligonucleotide was
inserted (Fig. 1C). The mutated PstI fragment was then cloned back into the
original PstI-digested pBlueL/LAT, and the resulting construct was designated
pBlueL/mLAT. Restriction enzyme mapping and DNA sequencing determined
the proper orientation of the PstI fragment. All cloning procedures (restriction
digests, ligations, calf intestinal phosphatase treatment, etc.) were performed by
standard procedures described previously (4, 13, 29).
The HSV-1 ICP0 (infected cell protein 0)-expressing plasmid was a gift from
S. Silverstein (Columbia University, Columbia, N.Y.).
Extraction of viral DNA. Isolation of intact BHV-1 viral DNA has been
previously described (1). Briefly, MDBK cells were infected with either BHV-1
Cooper or the LR mutant at an MOI of approximately 10. The clarified lysate
was pelleted using a 30% sucrose–Tris-EDTA cushion (25,000 rpm for 2 h in a
Beckman Lt-65 using an SW28 rotor at 4°C). Virions were disrupted with sodium
dodecyl sulfate (SDS) and RNase treatment, followed by proteinase K treatment
and extraction with phenol-chloroform-isoamyl alcohol (50:48:2). The integrity
and quantity of viral DNA were determined by 1% agarose gel electrophoresis.
Transfection and identification of the LR mutant. Bovine epidermal cells were
cotransfected with 6 g of pBlueL/mLAT, 2 g of a plasmid encoding HSV-1
ICP0, and 2 g of viral DNA (Cooper or LR mutant) by using Superfect
(Qiagen) as previously described (14).
Sixteen hours after transfection, the cells were split 1:2, incubated for 16
additional hours, and then overlaid with 0.7% SeaPlaque agarose. When visible
plaques appeared (3 to 4 days postinfection [p.i.]), each plaque was isolated,
propagated in MDBK cells, and screened by PCR for the mutant oligonucleotide
insert. PCR was performed on the extracted DNA using the p4 (nt 873; 5⬘CGT
GTATTTGCGACCCCCAGCCT3⬘) and p5 (nt 596; 5⬘GCCAGACCAAACCC
CCCGCA3⬘) primers (Fig. 1). After a hot start, each cycle consisted of 95°C for
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expression in all three reading frames (Fig. 1C). This mutation
was also designed to allow for WT levels of bICP0 expression.
The entire promoter and coding region of the LR gene was
cloned into the pBlueBacHisA vector as described in Materials
and Methods. A total of 825 bases from the adjacent HindIII L
fragment (18) were cloned upstream of the LR promoter to
ensure that efficient homologous recombination occurred. The
LR sequences between the two SphI sites (nt 781 to 812) were

replaced with the mutant oligonucleotide (Fig. 1C). The mutant oligonucleotide contains the first in-frame ATG of ORF2,
a unique EcoRI restriction site to facilitate screening, and
three stop codons that are in each reading frame. In transiently
transfected cells, this LR mutant gene construct expresses the
LR RNA, but the protein detected by a peptide antibody
directed against the N terminus of LR ORF2 (P2) is not detected (4, 13). Since alternative splicing of LR RNA occurs in
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FIG. 1. Schematic of the LR gene and the targeted site for mutagenesis. (A) Positions of IE transcripts (7, 37–39) and the LR transcript (27,
28) are presented. IE/4.2 is the IE transcript that encodes bICP4. IE/2.9 is the IE transcript that encodes bICP0. One IE promoter activates
expression of IE/4.2 and IE/2.9, and this IE transcription unit is designated IEtu1. E/2.6 is the early transcript that encodes bICP0. Exon 2 (e2)
of bICP0 contains all of the protein coding sequences of bICP0. The origin of replication (ORI) separates IEtu1 from IEtu2. IEtu2 encodes a
protein, bICP22. The solid lines in the transcript position map represent exons (e1, e2, and e3). The arrows indicate the direction of the respective
transcripts. (B) Partial restriction map, location of LR RNA, organization of LR ORF, and 3⬘ terminus of bICP0. The start sites for LR
transcription during latency and productive infection were previously described (5, 13). Reading frame C contains an ORF but lacks an initiating
Met. The asterisks denote the positions of stop codons that are in frame with the respective ORFs. A region of the HindIII L fragment was cloned
upstream of the LR gene, as described in Materials and Methods, to facilitate homologous recombination. The positions of the primers that were
used to amplify the mutated region of the LR gene were designated p4 and p5. The approximate location of the 3⬘ end of bICP22 is shown by the
arrow. (C) DNA sequence of the SphI fragment and the mutant oligonucleotide (oligo). The first ATG in the WT sequence is the first in-frame
ATG for ORF2 and is underlined. Stop codons in the mutant oligonucleotide are in all three reading frames (boldface and underlined). The EcoRI
restriction enzyme site (GAATTC) was incorporated into the mutant oligonucleotide to facilitate screening.
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trigeminal ganglia of calves during acute infection (5), it is
possible that a protein encoded by the LR gene could be
expressed, even if this mutation is present.
BHV-1 DNA was extracted from infected cells, and its integrity was examined by agarose gel electrophoresis. BHV-1
DNA is not very infectious when transfected into cultured
bovine epithelial cells. Efficient plaque formation was not observed at 14 days posttransfection, a time when cells were
lifting off the plates. When BHV-1 DNA and plasmids encoding bICP0 (14) or HSV-1 ICP0 (data not shown) were cotransfected into bovine cells, efficient plaque formation was consistently observed 48 h after transfection. A plasmid expressing
HSV-1 ICP0 was used for these studies because bICP0 sequences overlapped the LR mutant region, and thus we were
concerned this might reduce the efficiency of homologous recombination.
The viral genome was cotransfected into bovine epithelial
cells with HSV-1 ICP0 and the plasmid containing the mutant
oligonucleotide (pBlueL/mLAT). Plaques were isolated and
screened for insertion of the mutant oligonucleotide sequence

by PCR using the p4 and p5 primers (Fig. 1C). The amplified
products were then digested with EcoRI. If homologous recombination between the LR mutant plasmid and the viral
genome occurred, two bands (105 and 193 bp) would be observed following digestion with EcoRI (Fig. 2A lane 3). WT
virus yielded a single band (298 bp) as expected (Fig. 2A, lanes
1, 2, and 4). After the potential LR mutants were subjected to
three rounds of plaque purification, the same banding pattern
was observed, demonstrating that the mutant virus from a
plaque was not contaminated with WT virus and was stable.
(Fig. 2A, lanes 5 to 9). Occasionally, the WT band was detected
in some samples (Fig. 2A, lane 10, for example), indicating that
the EcoRI digestion was not complete or there was slight
contamination with WT virus. Several plaques containing the
mutant were selected and plaque purified two more times to
ensure they were not contaminated with WT virus.
To ensure that a resulting phenotype was not due to secondary site mutations, a rescued virus was constructed (LR
rescued virus). The LR mutant viral genome was cotransfected
with the WT LR gene cloned into pBlueBacHisA (pBlueL/
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FIG. 2. PCR of plaque-purified recombinant viruses. (A) Bovine epidermal cells were cotransfected with a plasmid encoding HSV-1 ICP0 (2
g), BHV-1 DNA (2 g), and pBlueL/mLAT (6 g). Plaques were isolated, and PCR was performed on extracted viral DNA using the p4 and
p5 primers (see Fig. 1C and Materials and Methods for the locations and sequences of these primers). Amplified products were digested with
EcoRI and visualized by ethidium bromide staining on 2% agarose gel electrophoresis. WT virus yields a single band migrating at 298 bp (oval),
while mutant oligonucleotide insertion yields two bands migrating at 105 and 193 bp (arrows). Lanes 1 and 2, WT virus plaques. Lane 3
pBlueL/mLAT plasmid DNA. Lane 4, pBlueL/LAT plasmid DNA. Lanes 5 to 9, viral DNA extracted from single plaques after the third round
of plaque purification of the LR mutant virus. Lane 10, example of a mixed-population virus stock. Lane 11, 100-bp ladder (New England BioLabs).
Lane 12, PCR positive control (WT Cooper strain viral DNA). (B) Bovine epidermal cells were cotransfected with a plasmid encoding HSV-1 ICP0
(2 g), LR mutant viral DNA (2 g), and pBlueL/LAT (6 g). Viral DNA was prepared from individual plaques, and PCR was performed using
the p4 and p5 primers. Lane 1, 100-bp ladder. Lanes 2 to 6, individual plaques from the third round of plaque purification of the LR rescued virus.
Lane 7, WT virus DNA. Lane 8, LR mutant DNA, which served as a PCR control.
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LAT) and a plasmid encoding HSV-1 ICP0 into bovine cells.
The p4 and p5 primers were used to identify amplified products that were not digested by EcoRI, which was indicative of
the LR WT gene. Figure 2B (lanes 2 to 6) shows five individual
plaques that were rescued back to the WT sequence. Viral
sequences encompassing the manipulated regions of the LR
gene in the LR mutant and LR rescued virus were sequenced
and contained the expected sequences (data not shown).
Analysis of the BHV-1 LR mutant virus in MDBK cells.
Infection of MDBK cells with BHV-1 Cooper strain produces
visible cytopathic effects by 7 to 10 h p.i. followed by efficient
plaque formation. IE gene expression can be detected within 1
to 2 h p.i. (6, 14, 30, 38, 39). Although not statistically significant, growth curves suggested that the mutant released virus
slightly faster from MDBK cells early in infection at an MOI of
1 (Fig. 3A). However, the end point titers were consistently the
same. At an MOI of 5, there were no differences in the titers
of cell-associated (data not shown) and released (Fig. 3B)
virus. The differences in the virus titers between Fig. 3A and B
were a result of the cells used to titer the virus in Fig. 3B being
more confluent. We have consistently observed that resting
cells or cells that are too confluent do not yield as much virus
as actively growing cells. However, this difference did not alter
our conclusion that the LR mutant and WT virus had similar
growth properties in MDBK cells. LR mutant, LR rescued,

and WT viruses also had similar growth properties in rabbit
epidermal (CCL-68; ATCC), rabbit lung (CCL-193; ATCC),
rabbit skin fibroblasts (CRL-1414; ATCC), and bovine epidermal cells (data not shown).
The LR RNA is antisense to the IE and E transcript that is
translated into bICP0 (20), suggesting bICP0 expression could
be altered by the mutation within the LR gene. Since bICP0 is
essential for productive viral replication (7, 14, 19), we compared expression of bICP0 in the WT, LR rescued, and LR
mutant viruses following infection of MDBK cells. These studies demonstrated that expression of bICP0 in MDBK cells
infected with the LR mutant was at least as high as in those
infected with the WT or the LR rescued virus (Fig. 4). In
several experiments, it appeared that the LR mutant expressed
slightly higher levels of bICP0.
Analysis of the LR mutant in calves. Calves were infected
with a total of 4 ⫻ 107 PFU of the WT, LR rescued, or LR
mutant virus/ml via the intranasal and intraocular routes as
described previously (30, 34, 36). Acute BHV-1 infection in
cattle lasts approximately 10 days. Significant amounts of ocular and nasal discharge were readily observed in all calves
infected with the WT or LR rescued virus (Table 1). Inflammation, herpetic lesions in the nostrils, and severe conjunctivitis were routinely detected on days 4 to 8 p.i. As a result of
these clinical symptoms, the calves go off feed for several days
and are listless (depressed) (Table 1). In contrast, the calves
infected with the LR mutant virus showed little discharge from
the nose or eyes and consequently did not exhibit severe clinical symptoms (Table 1).
Infectious virus was collected from ocular and nasal swabs in
2 ml of medium (Becton Dickinson, Franklin Lakes, N.J.).
Samples were subjected to two freeze-thaw cycles and clarified
by centrifugation, and then titers were determined on MDBK
cells. WT and LR rescued virus groups are considered one
group because there were no differences in the titers. At 1 day
p.i., similar titers of virus were detected in ocular swabs of
calves infected with the LR mutant or WT-LR rescued virus
group (Fig. 5). At all other time points, calves infected with the
LR mutant had 2 to 4 log units less virus in ocular swabs than
calves infected with the WT-LR rescued virus. At 6 days p.i.,
only 2 out of 10 calves infected with the LR mutant were
shedding measurable virus in ocular swabs. In contrast, the
WT-LR rescued virus group shed an average of 105 50% tissue
culture infective doses of virus at 6 days p.i.
From nasal swabs, the highest titer was obtained at 2 days
p.i. for all groups (9.0 tissue culture infective doses/ml) (Fig. 6).
Although we consistently detected 0.5- to 1-log-unit-lower titers in nasal swabs obtained from the LR mutant group, the
differences in titers between the WT-LR rescued virus group
and the LR mutant group were not significant. Considering
there was reduced nasal discharge from the LR mutant group,
it was somewhat surprising to find that viral titers in nasal
swabs collected from these calves were similar to those in
swabs from the WT-rescued virus group. Necropsy of the
calves infected with WT showed herpetic lesions and mucous
secretions in the turbinate at 6 and 10 days p.i. However, the
LR mutant group exhibited reduced lesions and secretions
(Table 1). In summary, these results demonstrated that the LR
mutant virus was not shed efficiently from the eyes of infected
calves but was shed efficiently from the nose.
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FIG. 3. Growth properties of WT and LR mutant viruses in MDBK
cells. Growth curves were performed as described in Materials and
Methods. (A) Cells were infected at an MOI of 1. LR mutant virus is
denoted by open symbols, and WT virus is denoted by solid symbols.
Released virus is denoted by ovals, and cell-associated virus is denoted
by rectangles. There were no significant differences between the
growth curves or final titers of WT and the LR mutant virus. (B) Cells
were infected at an MOI of 5. Solid ovals denote WT virus titers, and
open ovals denote LR mutant virus titers. The results are representative of four different experiments.
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To confirm that the LR mutant was secreted from infected
calves, DNA was extracted from ocular swabs prepared from
LR mutant- or WT virus-infected calves. Using primers p4 and
p5, PCR was performed, and the resulting products were digested with EcoRI. Prior to infection (0 days p.i.), viral DNA
was not detected for either group (Fig. 7). Virus was detected
in ocular swabs from 1 through 4 days p.i. from animals infected with the WT or LR mutant virus. After 4 days p.i., viral
DNA was not consistently detected in calves infected with the
LR mutant. In contrast, viral DNA was consistently detected at
days 6, 8, and 14 p.i. in calves infected with the WT virus.

Although data for only one animal are shown in Fig. 7, these
results are representative of several animals from each of the
groups.
Neutralizing-antibody titers are used to determine if animals
were vaccinated or previously infected with BHV-1 (17). This
suggests that an increase in the amount of virus replication and
shedding correlated with an increase of neutralizing-antibody
titers. At 10 and 14 days p.i., calves infected with the WT-LR
rescued virus produced higher titers of neutralizing antibodies
than calves infected with the LR mutant (Fig. 8). At 14 days
p.i., the WT-LR rescued group had an average titer of 78, but

TABLE 1. Clinical data obtained from calves infected with WT, rescued, or LR mutant viruses
Clinical symptom
Group

WT
LR rescued
LR mutant

Nasal sheddinga

Ocular sheddinga

Respiratory
distressb

Off
feedc

Conjunctivitisd

Secretion or lesions
in turbinatee

5–6 d (9.0 logunits)
5–6 d (9.0 logunits)
2–3 d (8.0 logunits)

5–6 d (7.2 logunits)
5–6 d (7.0 logunits)
0–1 d (5.5 logunits)

3–4 d
3–4 d
0–1 d

3d
3d
1.5 d

⫹⫹⫹⫹
⫹⫹⫹⫹
⫺⫺⫺

⫹⫹⫹⫹
ND
⫹

a
The values indicate the length of time during the acute infection that nasal and ocular secretions were observed on average for each group. d, days. The numbers
in parentheses indicate the highest titer obtained in each group during the time of shedding.
b
Respiratory distress was deemed to be present when animals presented signs such as shallow quick breaths, hanging head, and locked front legs. The values
represent the number of days (d) on average that each group showed the above-mentioned symptoms.
c
Calves were considered off feed if food remained 12 to 16 h after feeding. The value represents the number of days on average that each group showed this symptom.
d
A typical clinical sign of BHV-1 infection is conjunctivitis. Severe conjunctivitis (⫹⫹⫹⫹) was observed during the acute infection. No conjunctivitis (⫺⫺⫺) was
seen in calves infected with the LR mutant virus.
e
Calves were necropsied on days 0, 2, 4, 6, 10, and 14 p.i. A major amount of mucus (⫹⫹⫹⫹) was observed in the turbinates of calves infected with the WT virus,
whereas low levels of mucus (⫹) were observed in the LR mutant-infected group. Typical herpetic lesions were observed in the turbinate in the WT group (days 10
to 14 p.i.), whereas few lesions were observed in the LR-mutant group. ND, not done.
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FIG. 4. Western blot of bICP0 expression of WT, LR rescued, and LR mutant viruses during infection of MDBK cells. MDBK cells were
infected with the indicated viruses (MOI, 5), and whole-cell lysates were assayed for bICP0 expression at the indicated times. The membrane was
probed with a polyclonal rabbit serum directed against bICP0 (1:1,000 dilution), and bICP0 was detected with the ECL detection kit. The predicted
molecular mass of bICP0 is 97 kDa (7). We find that on an SDS–10% polyacrylamide gel electrophoresis gel, bICP0 routinely runs just below the
97-kDa protein marker. The membrane was stripped and reprobed for ␤-actin expression as a loading control.
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that of the LR mutant group was 20. In summary, this study
demonstrated that there was a correlation between reduced
ocular shedding of the LR mutant virus and neutralizing-antibody titers.
DISCUSSION
This report describes the construction, growth properties,
and gross pathogenesis of a BHV-1 LR mutant that contains
stop codons near the start site of LR transcription. This mutation should interfere with expression of proteins encoded by
the LR gene (Fig. 1) (13, 20). An earlier study demonstrated
that a peptide antibody directed against the amino terminus of
LR ORF2 recognized a 35- to 40-kDa protein in transiently
transfected cells, but insertion of this mutant oligonucleotide
interfered with its expression (4). The LR RNA has the potential to produce a family of proteins that may include functionally distinct proteins because alternative splicing occurs
after infection of calves or cultured cells (5, 13). Because of the
complicated nature of LR ORF organization and splicing of
the LR transcript, it is conceivable that the mutation we generated may not block expression of all proteins encoded by the
LR gene. We are currently developing additional antibodies
that will recognize these putative proteins to identify which

FIG. 6. Titer of nasal virus shedding. Nasal swabs were obtained at
the indicated times p.i. and were stored at ⫺80°C. Titers of the clarified lysate were determined on MDBK cells in quadruplicate. The cells
were stained with formalin and crystal violet to determine the 50%
endpoint. The solid symbols represent calves infected with the Cooper
virus strain, and the open symbols represent calves infected with the
LR mutant virus. Shown are the average means from each group at
each time indicated (n ⫽ 10 for the LR mutant, and n ⫽ 12 for the
Cooper-rescued group). All time points are not statistically significant:
P ⬎ 0.05. See the legend to Fig. 5 for an explanation of the statistical
methods used for this study.

ones are expressed following infection of calves and how this
mutation disrupts protein expression.
Shedding of the LR mutant from the eye was reduced 3 to 4
log units compared to that of WT or rescued virus (Fig. 5),
suggesting virus replication in the eye or optic nerve was inhibited. Curiously, the LR mutant virus produced slightly
larger plaques that lacked a distinct border compared to the
Cooper (WT) virus or the LR rescued virus in MDBK cells
(data not shown). However, the LR mutation had little effect
on virus growth (Fig. 3) following infection of MDBK cells.
Furthermore, similar levels of virus shedding were detected in
nasal swabs of calves infected with the different viruses (Fig. 6).
We have previously demonstrated that LR gene products interfere with cell cycle progression (29) and apoptosis in transiently transfected cells (4). It will be interesting to determine
if these activities are necessary for reduced virus shedding in
the eyes of infected calves. It is also possible that the LR
mutant does not play a direct role in virus replication. In
productively infected MDBK cells, the LR mutant virus appeared to be released slightly faster than WT or rescued virus
when the cells were infected at an MOI of 1 (Fig. 3A). If
premature shedding occurred in ocular tissue, the released
virus would likely be an easier target for immune recognition
and thus viral titers would be lower.
This study suggested that a mutation designed to interfere
with expression of LR proteins mediated the phenotype of the
LR mutant. The LR mutant appeared to produce slightly
higher levels of bICP0 expression in productively infected cells
(Fig. 4). If higher levels of bICP0 were expressed in certain cell
types during acute infection of calves, this could also have an
effect on virus growth because bICP0 is toxic to cells and
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FIG. 5. Titer of ocular virus shedding. Ocular swabs were obtained
at the indicated times p.i. and stored at ⫺80°C. Titers of the clarified
lysate were determined on MDBK cells in quadruplicate. The cells
were stained with formalin and crystal violet to determine the 50%
endpoint. The solid symbols represent calves infected with WT or LR
rescued virus, and the open symbols represent calves infected with LR
mutant virus. Shown are the average means from each group at each
time indicated. n ⫽ 10 for the LR mutant, and n ⫽ 12 for the WT-LR
rescued group. Calves infected with WT and LR rescued viruses
showed no observable differences, either in virus shedding or clinical
signs. From this point on, calves in the WT and LR rescued groups
were considered one group. Note that at 6 days p.i., only two calves
infected with the LR mutant shed virus, and at very low titers. Days 2,
4, 6, and 8 p.i. are statistically significant: P ⬍ 0.005. Statistical analysis
was performed using Microsoft Excel’s descriptive statistics. P values
represent the probability that the result occurred by chance, using 95%
confidence (a P value of ⬍0.05 is statistically significant). The error
bars represent the standard errors of the mean.
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activates productive infection (14). Finally, it is possible that
this small mutation has subtle effects on LR RNA expression in
certain cell types. Although the data presented in this study
strongly suggested that LR protein expression plays an important role in virus shedding in the eye, we cannot rule out the
possibility that increased bICP0 expression in certain cell types
contributed to the observed phenotype of the LR mutant.
The BHV-1 LR gene is considered by some to be a functional homologue of the HSV-1 gene encoding LAT. This
analogy can be made because LR RNA and LAT are abundantly expressed during latency, their RNA is localized in the
nuclei of latently infected neurons, and the respective RNAs
overlap and are antisense to a potent transcriptional activator
(bICP0 or ICP0) (16, 33). A number of studies have described
the growth properties of HSV-1 LAT mutants during infection
of rabbits or mice (16, 33). None of the published HSV-1 LAT
mutants exhibit reduced growth in the eyes of acutely infected
animals, suggesting that the LR gene has novel functions or
this phenotype is only observed in the natural host. In addition
to reduced ocular shedding, we predict that the LR mutant will
have reduced establishment and reactivation from latency because LAT sequences regulate establishment of latency (24)
and spontaneous reactivation (23) in rabbits. Studies designed
to address this hypothesis are in progress.
BHV-1 lacks several genes contained in the HSV-1 genome
which mediate pathogenesis and/or latency, for example, 34.5

FIG. 8. BHV-1 neutralizing-antibody titers. Serum was collected
from calves at the indicated times and stored at ⫺20°C until it was
tested. Standard testing was performed using constant amounts of
virus (Cooper strain) and twofold dilutions of the serum. The Veterinary Diagnostic Services, University of Nebraska, Lincoln, performed
the assay. Solid symbols represent calves infected with WT or LR
rescued virus. Open symbols represent calves infected with LR mutant
virus. Each time point represents at least 10 calves for each virus. Days
10 and 14 p.i. are statistically different (P ⬍ 0.005). See the legend to
Fig. 5 for an explanation of the statistical methods used for this study.
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FIG. 7. PCR of total DNA prepared from MDBK cells infected with ocular swabs. Clarified lysate from ocular swabs was obtained at the
indicated times p.i. and then used to infect MDBK cells. DNA was extracted, and PCR was performed using the primers p4 and p5 (described in
Materials and Methods). The amplified products were digested with EcoRI and visualized by ethidium bromide staining on a 2% agarose gel. The
positions of the WT sequence (not digested by EcoRI) and the LR mutant sequence (digested by EcoRI) are shown. Calves infected with the LR
mutant virus only shed virus on days 1 and 4 p.i. Calves infected with the WT virus shed only the WT virus, which was detected at 1, 4, 8, and 14
days p.i. The mutant and WT lanes contained plaque-purified viruses prior to infection of the calves. the molecular size ladder was the 100-bp
ladder from New England BioLabs.
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(31). The 34.5 gene plays a crucial role in neurovirulence by
inhibiting antiviral functions of the interferon-inducible double-stranded-RNA-dependent protein kinase R (PKR) (3, 21).
34.5 null mutants have reduced pathogenesis in rabbits and
mice, in large part because of poor growth properties in the
eyes and trigeminal ganglia (25). Although there does not
appear to be a high amino acid similarity between 34.5 and the
LR ORFs, it is tempting to speculate that the LR gene contains
certain LAT-like and 34.5-like functions. A better understanding of LR gene function will help to clarify its role in latency or
pathogenesis in cattle and may help us understand the differences in the genomes of alphaherpesviruses.
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